Skip to content
Grants Bay Logo
  • Home
  • Blog
  • Helpful Links
  • About
  • Contact Us
  • Privacy Policy
Previous Next

DoW Melanoma Research Program Focused Program Award – Rare Melanomas

Opportunity ID: 362244

General Information

Funding Opportunity Number HT942526MRPFPARM
Funding Opportunity Title DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Agency Jamie Shortall
Grant Officer
Document Type synopsis
Version 1
Opportunity Category Discretionary
Opportunity Category Explanation Not specified
Funding Instrument Type Grant
Category of Funding Activity Science and Technology and other Research and Development
Category Explanation Not specified
Expected Number of Awards 2
Cost Sharing or Matching Requirement No
Posted Date May 21, 2026 12:00:00 AM EDT
Last Updated Date May 21, 2026 12:43:23 PM EDT
Original Closing Date Oct 14, 2026 12:00:00 AM EDT
Original Closing Date Notes Not specified
Current Closing Date Oct 14, 2026 12:00:00 AM EDT
Current Closing Date Notes Not specified
Estimated Synopsis Date Not specified
Estimated Application Due Date Not specified
Estimated Award Date Not specified
Estimated Project Start Date Not specified
Archive Date Nov 13, 2026 12:00:00 AM EST
Estimated Total Program Funding 5,600,000
Award Ceiling none
Award Floor none

Assistance Listings

  • 12.420 — Military Medical Research and Development

Eligibility

Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Description

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.

Distinctive Features:

·          *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.

·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.

Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).

·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.

Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.

·        Clinical trials are allowed.

Additional Information

Contact Jamie Shortall
Grant Officer
Contact Information eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email help@eBRAP.org
Email Description eBRAP Help Desk
Phone 301-619-2393

Additional information

Version History

Version history

Opp hist id / Opportunity id 362244
Opp hist id / Revision 0
Opportunity id 362244
Revision 0
Opportunity number HT942526MRPFPARM
Opportunity title Melanoma Research Program Focused Program Award – Rare Melanomas
Owning agency code DOD-AMRAA
Opportunity category / Category D
Opportunity category / Description Discretionary
Forecast / Opp hist id / Opportunity id 362244
Forecast / Opp hist id / Revision 0
Forecast / Opportunity id 362244
Forecast / Revision 0
Forecast / Version 1
Forecast / Posting date May 05, 2026 12:00:00 AM EDT
Forecast / Forecast desc Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.  

Distinctive Features:

·      *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.

·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.

○       Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).

·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.

○       Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.

·        Clinical trials are allowed.

Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $5.6M to fund approximately 2 Focused Program Award – Rare Melanomas applications with total cost caps of $2.8M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.

Forecast / Cost sharing No
Forecast / Number of awards 2
Forecast / Estimated funding 5600000
Forecast / Award ceiling none
Forecast / Award floor none
Forecast / Agency contact name eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Forecast / Agency contact phone 301-682-5507
Forecast / Agency contact email help@eBRAP.org
Forecast / Agency contact email desc eBRAP Help Desk
Forecast / Agency code DOD-AMRAA
Forecast / Applicant eligibility desc Not specified
Forecast / Est synopsis posting date Jun 01, 2026 12:00:00 AM EDT
Forecast / Est application response date Oct 14, 2026 12:00:00 AM EDT
Forecast / Est application response date desc Not specified
Forecast / Est award date Sep 30, 2027 12:00:00 AM EDT
Forecast / Est project start date Sep 30, 2027 12:00:00 AM EDT
Forecast / Fiscal year 2026
Forecast / Create time stamp May 05, 2026 02:59:56 PM EDT
Forecast / Action type U
Forecast / Action date May 06, 2026 01:54:32 PM EDT
Forecast / Created date May 05, 2026 02:59:56 PM EDT
Forecast / Last updated date May 05, 2026 02:59:56 PM EDT
Forecast / Agency details / Code AMRAA
Forecast / Agency details / Seed DOD-AMRAA
Forecast / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Forecast / Agency details / Agency code DOD-AMRAA
Forecast / Agency details / Top agency code DOD
Forecast / Estimated funding formatted 5,600,000
Forecast / Applicant types 1 / Id 99
Forecast / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Forecast / Funding instruments 1 / Id CA
Forecast / Funding instruments 1 / Description Cooperative Agreement
Forecast / Funding instruments 2 / Id G
Forecast / Funding instruments 2 / Description Grant
Forecast / Funding activity categories 1 / Id ST
Forecast / Funding activity categories 1 / Description Science and Technology and other Research and Development
Forecast / Posting date str 2026-05-05-00-00-00
Forecast / Est synopsis posting date str 2026-06-01-00-00-00
Forecast / Est application response date str 2026-10-14-00-00-00
Forecast / Est award date str 2027-09-30-00-00-00
Forecast / Est project start date str 2027-09-30-00-00-00
Forecast / Create time stamp str 2026-05-05-14-59-56
Cfdas 1 / Id 433149
Cfdas 1 / Opportunity id 362244
Cfdas 1 / Revision 1
Cfdas 1 / Cfda number 12.420
Cfdas 1 / Program title Military Medical Research and Development
Synopsis modified fields Not specified
Forecast modified fields Not specified
Opp hist id / Opportunity id 362244
Opp hist id / Revision 2
Opportunity id 362244
Revision 2
Opportunity number HT942526MRPFPARM
Opportunity title DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Owning agency code DOD-AMRAA
Opportunity category / Category D
Opportunity category / Description Discretionary
Modified comments Adding "DoW" to the opportunity title
Forecast / Opp hist id / Opportunity id 362244
Forecast / Opp hist id / Revision 2
Forecast / Opportunity id 362244
Forecast / Revision 2
Forecast / Version 2
Forecast / Posting date May 05, 2026 12:00:00 AM EDT
Forecast / Forecast desc Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.  

Distinctive Features:
·      *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.
·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.
○       Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).
·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.
○       Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.
·        Clinical trials are allowed.

Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $5.6M to fund approximately 2 Focused Program Award – Rare Melanomas applications with total cost caps of $2.8M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.

Forecast / Cost sharing No
Forecast / Number of awards 2
Forecast / Estimated funding 5600000
Forecast / Award ceiling none
Forecast / Award floor none
Forecast / Agency contact name eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Forecast / Agency contact phone 301-682-5507
Forecast / Agency contact email help@eBRAP.org
Forecast / Agency contact email desc eBRAP Help Desk
Forecast / Agency code DOD-AMRAA
Forecast / Applicant eligibility desc Not specified
Forecast / Est synopsis posting date Jun 01, 2026 12:00:00 AM EDT
Forecast / Est application response date Oct 14, 2026 12:00:00 AM EDT
Forecast / Est application response date desc Not specified
Forecast / Est award date Sep 30, 2027 12:00:00 AM EDT
Forecast / Est project start date Sep 30, 2027 12:00:00 AM EDT
Forecast / Fiscal year 2026
Forecast / Mod comments Adding "DoW" to the opportunity title
Forecast / Create time stamp May 06, 2026 01:54:32 PM EDT
Forecast / Action type U
Forecast / Action date May 21, 2026 12:43:23 PM EDT
Forecast / Created date May 05, 2026 02:59:56 PM EDT
Forecast / Last updated date May 06, 2026 01:54:32 PM EDT
Forecast / Agency details / Code AMRAA
Forecast / Agency details / Seed DOD-AMRAA
Forecast / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Forecast / Agency details / Agency code DOD-AMRAA
Forecast / Agency details / Top agency code DOD
Forecast / Estimated funding formatted 5,600,000
Forecast / Applicant types 1 / Id 99
Forecast / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Forecast / Funding instruments 1 / Id CA
Forecast / Funding instruments 1 / Description Cooperative Agreement
Forecast / Funding instruments 2 / Id G
Forecast / Funding instruments 2 / Description Grant
Forecast / Funding activity categories 1 / Id ST
Forecast / Funding activity categories 1 / Description Science and Technology and other Research and Development
Forecast / Posting date str 2026-05-05-00-00-00
Forecast / Est synopsis posting date str 2026-06-01-00-00-00
Forecast / Est application response date str 2026-10-14-00-00-00
Forecast / Est award date str 2027-09-30-00-00-00
Forecast / Est project start date str 2027-09-30-00-00-00
Forecast / Create time stamp str 2026-05-06-13-54-32
Cfdas 1 / Id 433149
Cfdas 1 / Opportunity id 362244
Cfdas 1 / Revision 1
Cfdas 1 / Cfda number 12.420
Cfdas 1 / Program title Military Medical Research and Development
Synopsis modified fields Not specified
Forecast modified fields revision; version; opportunityTitle; forecastDesc; modComments; createTimeStamp

Forecast changes

revision

version

sendEmail

archiveDate

modComments

createTimeStamp

Id 362244
Revision 3
Opportunity number HT942526MRPFPARM
Opportunity title DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Owning agency code DOD-AMRAA
Modified comments Adding "DoW" to the opportunity title
Opportunity category / Category D
Opportunity category / Description Discretionary
Synopsis / Opportunity id 362244
Synopsis / Version 1
Synopsis / Agency code DOD-AMRAA
Synopsis / Agency name Jamie Shortall
Grant Officer
Synopsis / Agency phone 301-619-2393
Synopsis / Agency address desc eBRAP Help Desk
Synopsis / Agency details / Code AMRAA
Synopsis / Agency details / Seed DOD-AMRAA
Synopsis / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Synopsis / Agency details / Agency code DOD-AMRAA
Synopsis / Agency details / Top agency code DOD
Synopsis / Top agency details / Code DOD
Synopsis / Top agency details / Seed DOD
Synopsis / Top agency details / Agency name Department of Defense
Synopsis / Top agency details / Agency code DOD
Synopsis / Top agency details / Top agency code DOD
Synopsis / Agency contact phone 301-619-2393
Synopsis / Agency contact name Jamie Shortall
Grant Officer
Synopsis / Agency contact desc eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Synopsis / Agency contact email help@eBRAP.org
Synopsis / Agency contact email desc eBRAP Help Desk
Synopsis / Synopsis desc Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.

Distinctive Features:

·          *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.

·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.

                   Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).

·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.

                   Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.

·        Clinical trials are allowed.

Synopsis / Response date Oct 14, 2026 12:00:00 AM EDT
Synopsis / Response date desc Not specified
Synopsis / Posting date May 21, 2026 12:00:00 AM EDT
Synopsis / Archive date Nov 13, 2026 12:00:00 AM EST
Synopsis / Cost sharing No
Synopsis / Number of awards 2
Synopsis / Estimated funding 5600000
Synopsis / Estimated funding formatted 5,600,000
Synopsis / Award ceiling none
Synopsis / Award floor none
Synopsis / Applicant eligibility desc Not specified
Synopsis / Create time stamp May 21, 2026 12:44:03 PM EDT
Synopsis / Created date May 21, 2026 12:43:23 PM EDT
Synopsis / Last updated date May 21, 2026 12:43:23 PM EDT
Synopsis / Applicant types 1 / Id 99
Synopsis / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Synopsis / Funding instruments 1 / Id G
Synopsis / Funding instruments 1 / Description Grant
Synopsis / Funding activity categories 1 / Id ST
Synopsis / Funding activity categories 1 / Description Science and Technology and other Research and Development
Synopsis / Response date str 2026-10-14-00-00-00
Synopsis / Posting date str 2026-05-21-00-00-00
Synopsis / Archive date str 2026-11-13-00-00-00
Synopsis / Create time stamp str 2026-05-21-12-44-03
Agency details / Code AMRAA
Agency details / Seed DOD-AMRAA
Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Agency details / Agency code DOD-AMRAA
Agency details / Top agency code DOD
Top agency details / Code DOD
Top agency details / Seed DOD
Top agency details / Agency name Department of Defense
Top agency details / Agency code DOD
Top agency details / Top agency code DOD
Forecast / Opportunity id 362244
Forecast / Version 3
Forecast / Posting date May 05, 2026 12:00:00 AM EDT
Forecast / Archive date May 20, 2026 12:00:00 AM EDT
Forecast / Forecast desc Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Focused Program Award – Rare Melanomas, supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.  

Distinctive Features:
·      *Updated for FY26* Investigators must include at least one rare melanoma survivor or patient advocate as part of the project team who will provide advice and consultation throughout planning, implementation, and results dissemination to maximize research impact.
·        This is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.
○       Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).
·        After submitting the required pre-application, investigators must receive an invitation to submit a full application.
○       Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.
·        Clinical trials are allowed.

Funding Details: The Congressionally Directed Medical Research Programs expects to allot roughly $5.6M to fund approximately 2 Focused Program Award – Rare Melanomas applications with total cost caps of $2.8M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.

Forecast / Cost sharing No
Forecast / Number of awards 2
Forecast / Estimated funding 5600000
Forecast / Award ceiling none
Forecast / Award floor none
Forecast / Agency contact name eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Forecast / Agency contact phone 301-682-5507
Forecast / Agency contact email help@eBRAP.org
Forecast / Agency contact email desc eBRAP Help Desk
Forecast / Agency code DOD-AMRAA
Forecast / Applicant eligibility desc Not specified
Forecast / Est synopsis posting date Jun 01, 2026 12:00:00 AM EDT
Forecast / Est application response date Oct 14, 2026 12:00:00 AM EDT
Forecast / Est application response date desc Not specified
Forecast / Est award date Sep 30, 2027 12:00:00 AM EDT
Forecast / Est project start date Sep 30, 2027 12:00:00 AM EDT
Forecast / Fiscal year 2026
Forecast / Mod comments Updated Archive Date
Forecast / Create time stamp May 21, 2026 12:44:03 PM EDT
Forecast / Created date May 05, 2026 02:59:56 PM EDT
Forecast / Last updated date May 21, 2026 12:44:03 PM EDT
Forecast / Agency details / Code AMRAA
Forecast / Agency details / Seed DOD-AMRAA
Forecast / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Forecast / Agency details / Agency code DOD-AMRAA
Forecast / Agency details / Top agency code DOD
Forecast / Estimated funding formatted 5,600,000
Forecast / Applicant types 1 / Id 99
Forecast / Applicant types 1 / Description Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Forecast / Funding instruments 1 / Id CA
Forecast / Funding instruments 1 / Description Cooperative Agreement
Forecast / Funding instruments 2 / Id G
Forecast / Funding instruments 2 / Description Grant
Forecast / Funding activity categories 1 / Id ST
Forecast / Funding activity categories 1 / Description Science and Technology and other Research and Development
Forecast / Posting date str 2026-05-05-00-00-00
Forecast / Archive date str 2026-05-20-00-00-00
Forecast / Est synopsis posting date str 2026-06-01-00-00-00
Forecast / Est application response date str 2026-10-14-00-00-00
Forecast / Est award date str 2027-09-30-00-00-00
Forecast / Est project start date str 2027-09-30-00-00-00
Forecast / Create time stamp str 2026-05-21-12-44-03
Synopsis attachment folders 1 / Id 79848
Synopsis attachment folders 1 / Opportunity id 362244
Synopsis attachment folders 1 / Folder type Full Announcement
Synopsis attachment folders 1 / Folder name FY26 MRP FPARM
Synopsis attachment folders 1 / Zip lob size 685716
Synopsis attachment folders 1 / Created date May 21, 2026 12:43:42 PM EDT
Synopsis attachment folders 1 / Last updated date May 21, 2026 12:44:03 PM EDT
Synopsis attachment folders 1 / Synopsis attachments 1 / Id 352347
Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id 362244
Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type application/pdf
Synopsis attachment folders 1 / Synopsis attachments 1 / File name HT942526MRPFPARM_GG2.pdf
Synopsis attachment folders 1 / Synopsis attachments 1 / File description FY26 MRP FPARM Program Announcement
Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size 713899
Synopsis attachment folders 1 / Synopsis attachments 1 / Created date May 21, 2026 12:44:03 PM EDT
Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id 79848
Synopsis document urls Not specified
Syn att change comments Not specified
Cfdas 1 / Id 433149
Cfdas 1 / Opportunity id 362244
Cfdas 1 / Cfda number 12.420
Cfdas 1 / Program title Military Medical Research and Development
Opportunity pkgs 1 / Id 292888
Opportunity pkgs 1 / Topportunity id 362244
Opportunity pkgs 1 / Family id 14
Opportunity pkgs 1 / Dialect XFDL2.2
Opportunity pkgs 1 / Opportunity number HT942526MRPFPARM
Opportunity pkgs 1 / Opportunity title DoW Melanoma Research Program Focused Program Award – Rare Melanomas
Opportunity pkgs 1 / Cfda number 12.420
Opportunity pkgs 1 / Opening date 2026-05-21
Opportunity pkgs 1 / Closing date 2026-10-14
Opportunity pkgs 1 / Owning agency code DOD-AMRAA
Opportunity pkgs 1 / Agency details / Code AMRAA
Opportunity pkgs 1 / Agency details / Seed DOD-AMRAA
Opportunity pkgs 1 / Agency details / Agency name Defense Health Agency Contracting Activity – DHACA
Opportunity pkgs 1 / Agency details / Agency code DOD-AMRAA
Opportunity pkgs 1 / Agency details / Top agency code DOD
Opportunity pkgs 1 / Top agency details / Code DOD
Opportunity pkgs 1 / Top agency details / Seed DOD
Opportunity pkgs 1 / Top agency details / Agency name Department of Defense
Opportunity pkgs 1 / Top agency details / Agency code DOD
Opportunity pkgs 1 / Top agency details / Top agency code DOD
Opportunity pkgs 1 / Program title Military Medical Research and Development
Opportunity pkgs 1 / Contact info eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Opportunity pkgs 1 / Grace period 0
Opportunity pkgs 1 / Electronic required Y
Opportunity pkgs 1 / Expected application count 40
Opportunity pkgs 1 / Expected application size 1000000
Opportunity pkgs 1 / Open to applicant type 1
Opportunity pkgs 1 / Is multi project N
Opportunity pkgs 1 / Extension pdf
Opportunity pkgs 1 / Mimetype application/pdf
Opportunity pkgs 1 / Last update May 21, 2026 12:45:12 PM EDT
Opportunity pkgs 1 / Workspace compatible flag Y
Opportunity pkgs 1 / Package id PKG00292888
Opportunity pkgs 1 / Opening date str 2026-05-21-00-00-00
Opportunity pkgs 1 / Closing date str 2026-10-14-00-00-00
Closed opportunity pkgs Not specified
Original due date Oct 14, 2026 12:00:00 AM EDT
Original due date desc Not specified
Synopsis modified fields Not specified
Forecast modified fields revision; version; sendEmail; archiveDate; modComments; createTimeStamp
Error messages Not specified
Syn post date in past Yes
Doc type synopsis
Forecast hist count 2
Synopsis hist count 0
Assist compatible No
Assist url Not specified
Related opps Not specified
Ost POSTED

Related Documents

HT942526MRPFPARM_GG2.pdf

Packages

Agency Contact Information: eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00292888 2026-05-21 2026-10-14 View

Package 1

Instructions

PKG00292881-instructions.pdf

Mandatory forms

RR_SF424_5_0-V5.0.pdf
AttachmentForm_1_2-V1.2.pdf
RR_KeyPersonExpanded_4_0-V4.0.pdf
RR_Budget_3_0-V3.0.pdf
PerformanceSite_4_0-V4.0.pdf

Optional forms

RR_SubawardBudget30_3_0-V3.0.pdf

osnqt2026-10-06T20:57:27-05:00

Share This Post, Choose Your Platform!

XLinkedIn

About the Author: osnqt

Author avatar
Copyright 2012 - 2025 | All Rights Reserved
Page load link
Go to Top